We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+11.78%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$291M
AUM Growth
+$111M
Cap. Flow
+$101M
Cap. Flow %
34.52%
Top 10 Hldgs %
41.32%
Holding
85
New
36
Increased
17
Reduced
10
Closed
22

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$14.8M
2
BNGO icon
Bionano Genomics
BNGO
+$10.2M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.48M
4
UROV
Urovant Sciences Ltd.
UROV
+$6.99M
5
BIIB icon
Biogen
BIIB
+$6.64M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$5.97M
2
ELV icon
Elevance Health
ELV
+$4.88M
3
ICLR icon
Icon
ICLR
+$4.61M
4
WTW icon
Willis Towers Watson
WTW
+$3.94M
5
RVTY icon
Revvity
RVTY
+$3.85M

Sector Composition

Rank Sector Weight
1 Healthcare 74.76%
2 Financials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
76
Willis Towers Watson
WTW
$31.2B
– –
-25,969
Closed -$3.94M
ZTS icon
77
PUT
Zoetis
ZTS
$32.4B
– –
-16,000
Closed -$1.36M
ARAV
78
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-41,442
Closed -$504K
MRTX
79
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-60,050
Closed -$2.96M
RETA
80
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-43,842
Closed -$1.53M
XLRN
81
PUT
DELISTED
Acceleron Pharma
XLRN
– –
-16,700
Closed -$810K
GWPH
82
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-10,740
Closed -$1.5M
WCG
83
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-6,557
Closed -$1.61M
CTIC
84
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-31,600
Closed -$157K
CELG
85
DELISTED
Celgene Corp
CELG
– –
-41,942
Closed -$3.33M
1 2 3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Sio Capital Management held 85 positions worth $291M, up 61% from $181M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sio Capital Management deployed $101M of net new capital in Q3 2018, opening 36 new positions and adding to 17 existing holdings. Its largest new stake was GSK: 291,168 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 80% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Elevance Health, an estimated $4.88M trimmed.

  • Sio Capital Management's largest Q3 2018 buy was GSK: 291,168 shares worth $14.6M.
  • Sio Capital Management added most to Alnylam Pharmaceuticals in Q3 2018, an estimated $7.48M increase.
  • Sio Capital Management's biggest Q3 2018 reduction was Elevance Health, cutting an estimated $4.88M.
  • Sio Capital Management fully exited Boston Scientific in Q3 2018, selling an estimated $5.97M.
  • Sio Capital Management's ten largest holdings make up 41% of its $291M portfolio in Q3 2018.
  • Sio Capital Management opened 36 new positions and closed 22 in Q3 2018.
  • Sio Capital Management's portfolio value rose 61% quarter-over-quarter to $291M.

Based on Sio Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.